Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immune Response & Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccine.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00148941
First received: September 7, 2005
Last updated: October 6, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)